Status:

RECRUITING

Serratus Posterior Superior Intercostal Plane Block in Robotic-Assisted Thymectomy

Lead Sponsor:

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Conditions:

RATS Surgery

Thymectomy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study aims to assess the effectiveness of the Serratus Posterior Superior Intercostal Plane Block (SPSIP Block) for postoperative pain control, reducing opioid analgesic consumption, minimizing p...

Detailed Description

All patients enrolled in the study will receive the SPSIP Block under ultrasound guidance 15 minutes before entering the operating room. The SPSIP Block will be performed by the attending anesthetist ...

Eligibility Criteria

Inclusion

  • Patients affected by thymoma, thymic hyperplasia, or thymic pathologies (cysts, teratomas) who have given informed consent to the study.

Exclusion

  • Patients who refuse to participate in the study by not signing the informed consent;
  • Patients with myasthenia gravis, severe obesity (BMI \> 35), history of OSAS with or without CPAP;
  • Patients belonging to ASA classes \> 3, according to the system developed by the American Society of Anesthesiologists;
  • Patients unable to understand the functioning of the NPR Scale or the PCA device that will be used for postoperative analgesia;
  • Patients with allergies to analgesic and/or anesthetic drugs;
  • Patients on anticoagulant therapy;
  • Patients with a history of chronic pain;
  • Patients with an infection at the site where SPSIPB will be performed;
  • Patients who have had previous thoracic surgery and/or thoracic trauma with rib fractures on the side of the surgery;
  • Patients with chest deformities and/or neuromuscular diseases that interfere with normal ventilatory function.
  • Additionally, patients whose surgery is intraoperatively converted to sternotomy thymectomy will be excluded post-hoc from the study.

Key Trial Info

Start Date :

March 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 15 2026

Estimated Enrollment :

28 Patients enrolled

Trial Details

Trial ID

NCT06545409

Start Date

March 1 2025

End Date

September 15 2026

Last Update

March 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fondazione Policlinico A.Gemelli IRCCs

Rome, Italy, 00135